Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JamesK who wrote (574)	7/28/2021 10:15:10 AM
From: scaram(o)uche	of 684

Yeah, that would also be my guess. Thanks for your thought. Management team has relevant experience, and I may be back with additional thoughts. Today's pdsb release...... strange that NCI collaborators would allow efficacy updates at an investor conference?? But, as written, it sounds like we could get "Recent Phase 2 Human Clinical Data" as soon as 10 August. Could be in vitro data ("analyses of immune responses and other immune correlates are ongoing"), but doesn't sound like it. pdsbiotech.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next